D73.81

Clinical Causes: Chemotherapy or radiation therapy leading to bone marrow suppression Autoimmune disorders that target white blood cells Infections such as viral illnesses or bacterial infections that impact neutrophil levels Bone marrow diseases, including leukemia or myelodysplastic syndromes Splenic infiltration by malignant cells or certain hematologic conditions Nutritional deficiencies affecting blood cell production Genetic or hereditary disorders that cause immune system abnormalities

Key Symptoms: Enlarged spleen detectable via physical examination or imaging tests Lowered neutrophil count, leading to increased susceptibility to infections Unexplained fever or chills Fatigue or weakness Abdominal discomfort or fullness, especially in the upper left abdomen Unusual bleeding or easy bruising in some cases Recurrent infections due to immune compromise

Diagnosis Path: The diagnosis of neutropenic splenomegaly involves a combination of clinical evaluation and laboratory tests. A healthcare provider may perform physical examination to detect spleen enlargement and order blood tests to measure neutrophil counts. Imaging studies such as ultrasound, CT scan, or MRI can confirm spleen size and assess for any other related abnormalities. Bone marrow biopsies might be necessary to evaluate marrow health and identify underlying causes, especially in cases linked to hematological disorders.

Treatment Protocols: Managing neutropenic splenomegaly focuses on addressing the underlying condition causing neutropenia and spleen enlargement. Treatment options may include medications to stimulate neutrophil production, antibiotics for infections, or therapies targeting specific diseases like leukemia. In some cases, splenectomy (surgical removal of the spleen) might be considered when symptoms are severe or complications arise. Supportive care, such as immunizations and infection precautions, is also important to prevent complications.